Tag: ONVO

Finance

Bullish Stocks: OHR Pharmaceutical (NASDAQ:OHRP), Glu Mobile (NASDAQ:GLUU), Royale Energy (NASDAQ:ROYL), Organovo Holdings (NYSEMKT:ONVO), Methode Electronics (NYSE:MEI)

OHR Pharmaceutical Inc (NASDAQ:OHRP) soared today after Vista Partners updated its coverage for the pharmaceuticals company. Vista Partners has increased its twelve-month target price for OHR Pharmaceutical stock from $14 to $31. OHR Pharmaceutical Inc (NASDAQ:OHRP) stock performance was 35.43% in last session and finished the day at $9.90. Traded volume was 5.84million shares in the last session and the average volume of the stock … Continue reading Bullish Stocks: OHR Pharmaceutical (NASDAQ:OHRP), Glu Mobile (NASDAQ:GLUU), Royale Energy (NASDAQ:ROYL), Organovo Holdings (NYSEMKT:ONVO), Methode Electronics (NYSE:MEI)

Mark DeFrance
Finance

Healthcare Bullish Movers: Organovo Holdings (NYSEMKT:ONVO), Harvard Bioscience (NASDAQ:HBIO), Nature’s Sunshine Prod. (NASDAQ:NATR), Ruthigen (NASDAQ:RTGN), QLT (NASDAQ:QLTI)

In company news, Organovo Holdings ( ONVO ) advanced Thursday, with shares of the artificial-tissues company climbing as much as 12% after saying the head of mechanistic safety at Roche Holding AG ( RHHBY ) was able to distinguish a toxic drug known to cause liver injury from a similar but non-toxic compound using ONVO’s 3D human liver tissues. Organovo Holdings Inc (NYSEMKT:ONVO) stock performance … Continue reading Healthcare Bullish Movers: Organovo Holdings (NYSEMKT:ONVO), Harvard Bioscience (NASDAQ:HBIO), Nature’s Sunshine Prod. (NASDAQ:NATR), Ruthigen (NASDAQ:RTGN), QLT (NASDAQ:QLTI)

Richard Atkins
Finance

Healthcare Losers: Cytokinetics (NASDAQ:CYTK), Achillion Pharmaceuticals (NASDAQ:ACHN), Pharmacyclics (NASDAQ:PCYC), Organovo Holdings Inc (NYSEMKT:ONVO)

Cytokinetics, Inc. (NASDAQ:CYTK) announced disappointing top-line results from its BENEFIT-ALS midstage study involving tirasemtiv. Tirasemtiv did not meet its primary efficacy endpoint of delivering a mean change from baseline in the ALS functional rating scale. Cytokinetics, Inc. (NASDAQ:CYTK) stock performance was -64.67% in last session and finished the day at $4.59. Traded volume was 17.26million shares in the last session and the average volume of … Continue reading Healthcare Losers: Cytokinetics (NASDAQ:CYTK), Achillion Pharmaceuticals (NASDAQ:ACHN), Pharmacyclics (NASDAQ:PCYC), Organovo Holdings Inc (NYSEMKT:ONVO)

Kristen Barton